These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16361551)

  • 1. Expression of multidrug resistance-associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia.
    Plasschaert SL; de Bont ES; Boezen M; vander Kolk DM; Daenen SM; Faber KN; Kamps WA; de Vries EG; Vellenga E
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8661-8. PubMed ID: 16361551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis.
    Kubota H; Ishihara H; Langmann T; Schmitz G; Stieger B; Wieser HG; Yonekawa Y; Frei K
    Epilepsy Res; 2006 Mar; 68(3):213-28. PubMed ID: 16361082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High functional P-glycoprotein activity is more often present in T-cell acute lymphoblastic leukaemic cells in adults than in children.
    Plasschaert SL; Vellenga E; de Bont ES; van der Kolk DM; Veerman AJ; Sluiter WJ; Daenen SM; de Vries EG; Kamps WA
    Leuk Lymphoma; 2003 Jan; 44(1):85-95. PubMed ID: 12691146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia: correlation of expression and clinical outcome at first disease recurrence.
    Wu S; Gessner R; von Stackelberg A; Kirchner R; Henze G; Seeger K
    Cancer; 2005 Mar; 103(5):1054-63. PubMed ID: 15651075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of lung resistance protein and multidrug resistance-associated protein in naive childhood acute leukemia and their clinical significance].
    Zhang JB; Sun Y; Dong J; Liu LX; Ning F
    Ai Zheng; 2005 Aug; 24(8):1015-7. PubMed ID: 16086885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity and expression of the multidrug resistance proteins P-glycoprotein, MRP1, MRP2, MRP3 and MRP5 in de novo and relapsed acute myeloid leukemia.
    van der Kolk DM; de Vries EG; Noordhoek L; van den Berg E; van der Pol MA; Müller M; Vellenga E
    Leukemia; 2001 Oct; 15(10):1544-53. PubMed ID: 11587212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of cyclin D1 in de novo and relapsed childhood acute lymphoblastic leukemia.
    Sauerbrey A; Häfer R; Zintl F; Volm M
    Anticancer Res; 1999; 19(1B):645-9. PubMed ID: 10216470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential mRNA expression of glucocorticoid receptor alpha and beta is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children.
    Koga Y; Matsuzaki A; Suminoe A; Hattori H; Kanemitsu S; Hara T
    Pediatr Blood Cancer; 2005 Aug; 45(2):121-7. PubMed ID: 15704223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between expression of GYPC and TRIP3 genes and prognosis of acute lymphoblastic leukemia in children].
    Zhang JB; Li XH; Ning F; Guo XS
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan; 11(1):29-32. PubMed ID: 19149918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of multidrug resistance gene(mdr1) expression in patients with acute leukemia].
    Dong Z; Luo J; Xu W
    Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):72-5. PubMed ID: 10743063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of the reduced folate carrier, the major membrane transporter for methotrexate, in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    Ge Y; Haska CL; LaFiura K; Devidas M; Linda SB; Liu M; Thomas R; Taub JW; Matherly LH
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):451-7. PubMed ID: 17255265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to chemotherapy and expression of the genes encoding the multidrug resistance-associated proteins MRP2, MRP3, MRP4, MRP5, and SMRP in childhood acute myeloid leukemia.
    Steinbach D; Lengemann J; Voigt A; Hermann J; Zintl F; Sauerbrey A
    Clin Cancer Res; 2003 Mar; 9(3):1083-6. PubMed ID: 12631611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype.
    Steinbach D; Wittig S; Cario G; Viehmann S; Mueller A; Gruhn B; Haefer R; Zintl F; Sauerbrey A
    Blood; 2003 Dec; 102(13):4493-8. PubMed ID: 12816874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of multidrug resistance gene (MDR1) at relapse in a child with acute lymphoblastic leukemia.
    Kourti M; Vavatsi N; Gombakis N; Tzimagiorgis G; Sidi V; Koliouskas D; Athanassiadou F
    Pediatr Hematol Oncol; 2006 Sep; 23(6):489-94. PubMed ID: 16849280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of late cell cycle genes and an increased proliferative capacity characterize very early relapse of childhood acute lymphoblastic leukemia.
    Kirschner-Schwabe R; Lottaz C; Tödling J; Rhein P; Karawajew L; Eckert C; von Stackelberg A; Ungethüm U; Kostka D; Kulozik AE; Ludwig WD; Henze G; Spang R; Hagemeier C; Seeger K
    Clin Cancer Res; 2006 Aug; 12(15):4553-61. PubMed ID: 16899601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of multidrug resistance protein in adult T-cell leukemia.
    Ohno N; Tani A; Chen ZS; Uozumi K; Hanada S; Akiba S; Ren XQ; Furukawa T; Sumizawa T; Arima T; Akiyama SI
    Clin Cancer Res; 2001 Oct; 7(10):3120-6. PubMed ID: 11595704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of lung resistance protein and multidrug resistance-related protein (MRP1) in pediatric acute lymphoblastic leukemia.
    El-Sharnouby JA; Abou El-Enein AM; El Ghannam DM; El-Shanshory MR; Hagag AA; Yahia S; Elashry R
    J Oncol Pharm Pract; 2010 Sep; 16(3):179-88. PubMed ID: 19969624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody binding capacity for evaluation of MDR-related proteins in acute promyelocytic leukemia: Onset versus relapse expression.
    Damiani D; Michieli M; Michelutti A; Candoni A; Stocchi R; Masolini P; Geromin A; Michelutti T; Raspadori D; Ippoliti M; Lauria F; Fanin R
    Cytometry B Clin Cytom; 2004 May; 59(1):40-5. PubMed ID: 15108169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of liposomal daunorubicin and cytarabine as reinduction chemotherapy in relapsed acute lymphoblastic leukaemia despite expression of multidrug resistance-related proteins.
    Candoni A; Michelutti A; Simeone E; Damiani D; Baccarani M; Fanin R
    Eur J Haematol; 2006 Oct; 77(4):293-9. PubMed ID: 16856922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.